Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher Peetz

Christopher Peetz is recorded as CEO at Mirum Pharmaceuticals, Inc. (MIRM). The proxy statement of Mirum Pharmaceuticals, Inc. reports total compensation of $10,441,224 for Christopher Peetz in fiscal 2025, including a base salary of $755,000. Disclosed compensation is on record for 8 fiscal years. Christopher Peetz has spoken on 4 earnings calls across 1 company, most recently for Mirum Pharmaceuticals, Inc. on January 13, 2025.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Mirum Pharmaceuticals, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Mirum Pharmaceuticals, Inc. (MIRM) $755,000 $10,441,224
2024 Mirum Pharmaceuticals, Inc. (MIRM) $730,000 $6,598,551
2023 Mirum Pharmaceuticals, Inc. (MIRM) $660,000 $6,451,720
2022 Mirum Pharmaceuticals, Inc. (MIRM) $624,000 $4,402,664
2021 Mirum Pharmaceuticals, Inc. (MIRM) $600,000 $4,130,831
2020 Mirum Pharmaceuticals, Inc. (MIRM) $511,818 $3,003,978
2019 Mirum Pharmaceuticals, Inc. (MIRM) $457,614 $6,235,185
2018 Mirum Pharmaceuticals, Inc. (MIRM) $32,083 $32,083

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.